pubrio
Fosun Pharma

Fosun Pharma

China · Pharmaceuticals

Pharmaceuticals

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group. Fosun Pharma directly operates businesses including pharmaceuticals, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business. Fosun Pharma is patient-centered and clinical needs-oriented. The company continuously enriches its innovative product pipeline through independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma improves the research and clinical development capabilities of FIC (First-in-class) and BIC (Best-in-class) new drugs as well as accelerates the R&D and launch of innovative technologies and products.

Company Insights
Company Overview

1994

Founded

Pharmaceuticals

Industry

China

Location

279,993,719

Ranking

41,000 employees

Size

Similar Companies
Similiar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Fosun Pharma

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Talk to Our Team
Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

Call Center

85259256922

Our Location

15th Floor ADGM Square, UAE

Social Network

© Pubrio 2026